Evidence map›Paper›PMID 34095557›Full record

ArticleClinical and translational radiation oncology2021

A radiomics-based model for predicting local control of resected brain metastases receiving adjuvant SRS.

Kellen Mulford, Chuyu Chen, Kathryn Dusenbery, Jianling Yuan, Matthew A Hunt, Clark C Chen, Paul Sperduto, Yoichi Watanabe, Christopher Wilke

Open access · goldAbstract read
In one paragraph

Article in Clinical and translational radiation oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Computational Modeling and AI in Radiation Neuro-Oncology and Radiosurgery.Advances in experimental medicine and biology · 2024
    Review
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Kellen MulfordDepartment of Radiation Oncology, University of Minnesota, Minneapolis, MN, USA.
Chuyu ChenDepartment of Radiation Oncology, University of Minnesota, Minneapolis, MN, USA.
Kathryn DusenberyDepartment of Radiation Oncology, University of Minnesota, Minneapolis, MN, USA.
Jianling YuanDepartment of Radiation Oncology, University of Minnesota, Minneapolis, MN, USA.
Matthew A HuntDepartment of Neurosurgery, University of Minnesota, Minneapolis, MN, USA.
Clark C ChenDepartment of Neurosurgery, University of Minnesota, Minneapolis, MN, USA.
Paul SperdutoMinneapolis Radiation Oncology and Gamma Knife Center, Minneapolis, MN, USA.
Yoichi WatanabeDepartment of Radiation Oncology, University of Minnesota, Minneapolis, MN, USA.
Christopher WilkeDepartment of Radiation Oncology, University of Minnesota, Minneapolis, MN, USA.
University of Minnesota · USMinnesota Oncology · US

Funding

University of Minnesota Clinical and Translational Science Institute (UMN CTSI)UL1TR002494 · NCATS · UNIVERSITY OF MINNESOTA · PI BLAZAR, BRUCE R, WEISDORF, DANIEL J · 2018 to 2022
$34.9M
NRSA Training CoreTL1TR002493 · NCATS · UNIVERSITY OF MINNESOTA · PI FULKERSON, JAYNE ALLYN · 2018 to 2022
$3.1M
NCATS NIH HHS TL1 TR002493NCATS NIH HHS UL1 TR002494
6 · The paper itself

Abstract

purposeAdjuvant radiosurgery to the cavities of surgically resected brain metastases provides excellent local tumor control while reducing the risk of deleterious cognitive decline associated with whole brain radiotherapy. A subset of these patients, however, will develop disease recurrence following radiosurgery. In this study, we sought to assess the predictive capability of radiomic-based models, as compared with standard clinical features, in predicting local tumor control.

methodsWe performed a retrospective chart review of patients treated with adjuvant radiosurgery for resected brain metastases at the "Institution" from 2009 to 2019. Shape, intensity and texture based radiomics features of the cavities were extracted from the pre-radiosurgery treatment planning MRI scans and trained using a gradient boosting technique with K-fold cross validation.

resultsIn total, 71 cavities from 67 treated patients were included for analysis. The 6 and 12 month local control estimates were 86% and 76%, respectively. The 6 and 12 month overall survival was 78% and 55%, respectively. Thirty-six patients developed intracranial failures outside of the surgical cavity. The predictive model for local control trained on imaging features from the whole cavity achieved an area-under-the-curve (AUC) of 0.73 on the validation set versus an AUC of 0.40 for the clinical features.

conclusionsHere we report a single institutional experience using radiomic-based predictive modeling of local tumor control following adjuvant Gamma Knife radiosurgery for resected brain metastases. We found the radiomics features to provide more robust predictive models of local control rates versus clinical features alone. Such techniques could potentially prove useful in the clinical setting and warrant further investigation.

Indexed as

Brain metastasesGamma KnifeLocal controlRadiomics

Identifiers

PMID34095557
PMCPMC8164004
OpenAlexW3163475009

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.